Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,415Revenue $M2,133Net Margin (%)3.7Z-Score3.5
Enterprise Value $M3,211EPS $2.7Operating Margin %8.0F-Score5
P/E(ttm))53.4Cash Flow Per Share $6.5Pre-tax Margin (%)5.3Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %9.0Quick Ratio2.6Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %-1.3Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow16.0y-y EBITDA Growth Rate %-21.3ROA % (ttm)2.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)3.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.8ROI % (ttm)3.8Gross Margin Increase y-yY

Gurus Latest Trades with BIO

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIOJohn Burbank 2014-03-31 Buy 0.02%$121.07 - $133.73
($128.05)
$ 118.5-8%New holding, 4652 sh.4,652
BIOJoel Greenblatt 2013-03-31 Sold Out -0.04%$105.05 - $126
($117.3)
$ 118.51%Sold Out0
BIOJoel Greenblatt 2012-12-31 Reduce-0.09%$100.02 - $109.55
($103.99)
$ 118.514%Reduce -65.94%6,350
BIOGeorge Soros 2012-09-30 Sold Out -0.02%$92.4 - $109.42
($101.33)
$ 118.517%Sold Out0
BIOMario Gabelli 2012-06-30 Add0.07%$95.57 - $116
($103.12)
$ 118.515%Add 2335.14%90,100
BIOGeorge Soros 2012-06-30 Buy 0.02%$95.57 - $116
($103.12)
$ 118.515%New holding, 15000 sh.15,000
BIOJoel Greenblatt 2012-03-31 Add0.07%$96.64 - $105.67
($94.65)
$ 118.525%Add 56.04%22,134
BIOJoel Greenblatt 2011-12-31 Buy 0.16%$88.92 - $102.55
($95.3)
$ 118.524%New holding, 14185 sh.14,185
BIOGeorge Soros 2011-06-30 Sold Out $117.11 - $126.34
($121.89)
$ 118.5-3%Sold Out0
BIOGeorge Soros 2011-03-31 Buy 0.01%$103.85 - $119.58
($111.64)
$ 118.56%New holding, 3900 sh.3,900
BIOMario Gabelli 2011-03-31 Reduce$103.85 - $119.58
($111.64)
$ 118.56%Reduce -60.67%3,500
BIOGeorge Soros 2007-12-31 Sold Out -0.01%$92.28 - $106.51
($100.3)
$ 118.518%Sold Out0
BIOGeorge Soros 2007-09-30 Buy 0.01%$74.2 - $90.5
($81.6)
$ 118.545%New holding, 3997 sh.3,997
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIO John Burbank 2014-03-314,6520.020.02New Buy
BIO Mario Gabelli 2014-03-3194,6000.330.07-2.87%
Premium Most recent portfolio changes are included for Premium Members only!


BIO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BIO :

    Quarterly/Annual Reports about BIO:

    News about BIO:

    Articles On GuruFocus.com
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 23 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 14 2014 
    Different Opinions on Bio-Rad Laboratories Apr 03 2014 
    John Rogers Commentaries on Healthcare Stocks: BIO, RX, TMO, LH, HSP, ZMH, MRK Oct 02 2009 
    Patient Investor John Rogers likes Sotheby, Citigroup, Bio-Rad Laboratories, Inc Mar 23 2008 

    More From Other Websites
    NYSE stocks posting largest volume increases Jul 21 2014
    Bio-Rad to Report Second-Quarter 2014 Financial Results Tuesday, August 5, 2014 Jul 07 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Jun 26 2014
    Bio-Rad Unveils Vitamin-D Test in International Market Jun 24 2014
    Bio-Rad Launches Vitamin D Kit for Its BioPlex 2200 System Jun 23 2014
    Bio-Rad Launches the First Fully-Automated 5th Generation HIV Test Jun 17 2014
    BIO RAD LABORATORIES INC Financials May 16 2014
    Levin Capital reports 5.2% passive stake in Bio-Rad May 08 2014
    BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report May 08 2014
    Bio-Rad Laboratories' (BIO) CEO Norman Schwartz on Q1 2014 Results - Earnings Call Transcript May 06 2014
    Q1 2014 Bio Rad Laboratories In Earnings Conference Call (BIO) Q1 2014 Results - Earnings Call... May 06 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 06 2014
    Bio-Rad Reports First-Quarter 2014 Financial Results May 06 2014
    Q1 2014 Bio-Rad Laboratories, Inc. Earnings Release - After Market Close May 06 2014
    Bio-Rad Named One of the '2014 Best Places to Work in the Bay Area' Apr 28 2014
    BIO RAD LABORATORIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Apr 25 2014
    The Equation For Quotient Ltd. IPO Still Doesn't Look Positive Apr 21 2014
    Bio-Rad to Report First-Quarter 2014 Financial Results Tuesday, May 6, 2014 Apr 16 2014
    Bio-Rad Buys GnuBio Apr 14 2014
    Bio-Rad acquires GnuBIO, terms undisclosed Apr 10 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide